Digital Health Innovators: Senseonics’ Francine Kaufman In the most recent of the Health Innovators video series, pharmaphorum's founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics.
News Senseonics, TypeZero to develop artificial pancreas Deal will combine inControl algorithms with Eversense CGM.
News Senseonics' implantable glucose monitor passes test Company now looking to file for pre-marketing approval.
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.